Szawarnoga, D.; Fojcik, J.; Górski, M.; Pałasz, A.; Krzystanek, M.
Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study. Pharmaceuticals 2025, 18, 1066.
https://doi.org/10.3390/ph18071066
AMA Style
Szawarnoga D, Fojcik J, Górski M, Pałasz A, Krzystanek M.
Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study. Pharmaceuticals. 2025; 18(7):1066.
https://doi.org/10.3390/ph18071066
Chicago/Turabian Style
Szawarnoga, Daniel, Joanna Fojcik, Michał Górski, Artur Pałasz, and Marek Krzystanek.
2025. "Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study" Pharmaceuticals 18, no. 7: 1066.
https://doi.org/10.3390/ph18071066
APA Style
Szawarnoga, D., Fojcik, J., Górski, M., Pałasz, A., & Krzystanek, M.
(2025). Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study. Pharmaceuticals, 18(7), 1066.
https://doi.org/10.3390/ph18071066